bromodeoxyuridine has been researched along with safranine t in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arima, N; Inagaki, Y; Kato, S; Kojiro, M; Kume, S; Nagata, K; Okawa, T; Ueda, S; Yamagishi, S | 1 |
1 other study(ies) available for bromodeoxyuridine and safranine t
Article | Year |
---|---|
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Topics: Acetaldehyde; Adipocytes; Adipose Tissue; Apoptosis; Blotting, Western; Bone and Bones; Bromodeoxyuridine; Calcium; Cartilage; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Cells, Cultured; Chondrocytes; Collagen Type II; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glucose; Glycation End Products, Advanced; Glyceraldehyde; Humans; Immunohistochemistry; Lipoprotein Lipase; Mesenchymal Stem Cells; Microscopy, Fluorescence; Microscopy, Immunoelectron; Microscopy, Phase-Contrast; Osteocytes; Phenazines; Reactive Oxygen Species; Stem Cells; Time Factors; Wound Healing | 2005 |